Radboudumc and partners

Innovation requires collaboration

Our mission is to have a significant impact on healthcare. We aim to be a front runner in the development of sustainable, innovative, and affordable healthcare.

collaboration
opportunities

contact

news

spin-off companies

licensing opportunities

our collaborations

News

setup e-mail alert

Enzyre closes Series A financing round of €12M to advance pioneering diagnostic technology platform for hemophilia patients

2 November 2022

Enzyre has announced that it has successfully raised €12 million in a Series A financing led by new investor, Oost NL, with participation from i&i Biotech Fund, Demcon Investment, Takeda Ventures, and Novalis Biotech. Part of the funding is an Innovation Credit from the Dutch Government.

Aiosyn selected as finalist for OostNL's Startversneller vote now!

18 October 2022

The 6 finalists of the election “Starter with impact Eastern Netherlands 2022” have been announced and Radboudumc’s Aiosyn is one of them.

Successful matchmaking at Radboudumc Investment Day

7 October 2022

On the 5th of October, over 100 scientists, investors and entrepreneurs came together at the second Radboudumc Investment Day, jointly hosted by Radboudumc, Oost NL and Briskr.

SPL Medical announces collaboration with NanoEcho for application of Ferrotran® (Ferumoxtran) for Ultrasound detection of Lymph node metastases

30 September 2022

SPL medical and NanoEcho have signed a Letter of Intent and initiated a cooperation on regulatory partnership and supply for SPL medical proprietary iron-based nanoparticle Ferrotran® (Ferumoxtran) product and platform.

Radboudumc Investment Day 2022

26 September 2022

Get ready for Radboudumc Investment Day 2022: October 5 in Nijmegen!

Setup e-mail alerts

Something went wrong!

Something went wrong while requesting this page. Please try again.

Email address *

Would you like to receive e-mail updates?

Select the frequency of how often you would like to receive an e-mail alert

None Immediate Daily Weekly